Stockreport

Compass Therapeutics Provides Corporate Update [Yahoo! Finance]

Compass Therapeutics, Inc.  (CMPX) 
PDF study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with advanced biliary tract cancer (BTC). In the ongoing Phase 1 dose-escalation study of CTX-8371 ( [Read more]